← Leaderboards
Justin Joseph Pollara
Duke University
$7,100,830
Attributed
$9,008,381
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,008,381 · 7
By mechanism
P01$4,268,780 · 2
R01$2,022,450 · 2
U01$1,239,565 · 1
K01$1,040,336 · 1
R21$437,250 · 1
Top collaborators
- Andrew Serghios Barbas4 shared
- Todd Victor Brennan4 shared
- Todd Christopher Bradley1 shared
- Wilton B Williams1 shared
Most similar at Duke University
Same institution · by research overlap
- Alejandro Aballay$11,930,620
- Staci D Bilbo$12,627,005
- Pamela Susan Douglas$66,022,992
- Matthias Gromeier$11,871,021
- Todd Victor Brennan$1,184,672
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneImmune ResponseInfectionClinical TrialsResponseCellsInnovationHiv-1MediatingAntibodiesAntigensAntibody ResponseMacaca MulattaLifeSamplingGenerationsPublic HealthUnited States National Institutes Of HealthExperimental StudyNeutralizing AntibodyProphylacticFoundationsMissionVaccine Candidate
Grant awards (16)
Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses$1,239,565
U01 · FY2025 · AI
Physical Resources Core$1,005,214
P01 · FY2025 · AI · contact PI
Physical Resources Core$778,959
P01 · FY2024 · AI · contact PI
Physical Resources Core$774,432
P01 · FY2023 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$403,171
R01 · FY2023 · AI · contact PI
Physical Resources Core$822,707
P01 · FY2022 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$403,163
R01 · FY2022 · AI · contact PI
Physical Resources Core$887,468
P01 · FY2021 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$407,815
R01 · FY2021 · AI · contact PI
Functional profile to HIV vaccine elicited antibodies in infants$400,688
R01 · FY2021 · AI · contact PI
Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns$407,613
R01 · FY2020 · AI · contact PI
Combined Hepatitis B and HIV-1 envelope vaccination to augment T cell help via linked recognition of unrelated antigens$343,661
K01 · FY2019 · OD · contact PI
Combined Hepatitis B and HIV-1 envelope vaccination to augment T cell help via linked recognition of unrelated antigens$346,922
K01 · FY2018 · OD · contact PI
Combined Hepatitis B and HIV-1 envelope vaccination to augment T cell help via linked recognition of unrelated antigens$349,753
K01 · FY2017 · OD · contact PI
Dual-Affinity Re-Targeting Proteins for Cure of Newborn Infant HIV-1 Infection$159,000
R21 · FY2017 · AI · contact PI
Dual-Affinity Re-Targeting Proteins for Cure of Newborn Infant HIV-1 Infection$278,250
R21 · FY2016 · AI · contact PI